LoginRegister
    Price of Santizers capped at Rs 100 per 200 ml, Surgical mask at Rs 10Price of Santizers capped at Rs 100 per 200 ml, Surgical mask at Rs 10
    Novartis to donate up to 130 million doses of hydroxychloroquine for COVID-19Novartis to donate up to 130 million doses of hydroxychloroquine for COVID-19
    Glenmark Pharmaceuticals gets tentative ANDA nod for Dapagliflozin TabletsGlenmark Pharmaceuticals gets tentative ANDA nod for Dapagliflozin Tablets
    Coronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugsCoronavirus: PM Modi Interacts with Pharma leaders to ensure no shortage of drugs
    USFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine SulphateUSFDA partially lifts import ban on Ipca Labs APIs of Chloroquine Phosphate and Hydroxychloroquine...
    Cabinet nod to Rs 3000 crore for 3 Bulk Drug parks , Rs 6950 crore Production Linked Incentive Scheme for domestic production of APIsCabinet nod to Rs 3000 crore for 3 Bulk Drug parks , Rs 6950 crore Production Linked Incentive...
    Cabinet approves big package for promotion of Domestic Manufacturing of Medical Devices, detailsCabinet approves big package for promotion of Domestic Manufacturing of Medical Devices, details
    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)
    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.
    GE Healthcare to produce ventilators round-the-clock to meet coronavirus-led demandGE Healthcare to produce ventilators round-the-clock to meet coronavirus-led demand
    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19
    Novartis receives Japanese approval for Zolgensma for spinal muscular atrophyNovartis receives Japanese approval for Zolgensma for spinal muscular atrophy
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    sidekick